Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.014
Buy
RSI(14)
55.690
Neutral
STOCH(KDJ)(9,3,3)
70.039
Neutral
ATR(14)
0.109
Low Volatility
CCI(14)
65.229
Neutral
Williams %R
26.172
Buy
TRIX(12,20)
0.478
Sell
StochRSI(14)
0.000
Sell
Search
Alzamend Neuro Inc
ALZNAdd to Watchlist
1.310USD
-0.040-2.96%
Close 07-31 16:00（ET）Quotes delayed by 15 min
113.35KMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.96%
5 Days
-1.50%
1 Month
+16.96%
6 Months
-39.07%
Year to Date
-28.02%
1 Year
-41.78%
Key Figures
1.360Open
1.360High
24.82KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
28.68%Turnover Ratio
1.350Prev. Close
1.290Low
28.98KTurnover
LossP/E Static
0.03P/B
0.00%Div Yield TTM
-171.39%ROA
8.22052wk High
0.75Volume Ratio
-5.11MNet Profit
86.53KShares
-94.2683EPS TTM
0.14Beta
-267.81%ROE
0.84052wk Low
5.19%Amplitude
--Gross Margin
113.35KMarket Cap
3.35Reward/Risk
4.88%Risk Rate
Alzamend Neuro Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
25.000
Target Price
+1765.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Alzamend Neuro Inc
ALZN
1
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.330
Sell
MA10
1.317
Sell
MA20
1.250
Buy
MA50
1.215
Buy
MA100
1.243
Buy
MA200
1.706
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Alzamend Neuro Inc Info
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's by removing beta-amyloid from the brain through a royalty-bearing exclusive worldwide license from the Licensor.
Ticker SymbolALZN
CompanyAlzamend Neuro Inc
CEOJackman (Stephan)
Websitehttps://alzamend.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Alzamend Neuro Inc (ALZN)?
The current price of Alzamend Neuro Inc (ALZN) is 1.31.
What is the symbol of Alzamend Neuro Inc?
The ticker symbol of Alzamend Neuro Inc is ALZN.
What is the 52-week high of Alzamend Neuro Inc?
The 52-week high of Alzamend Neuro Inc is 8.22.
What is the 52-week low of Alzamend Neuro Inc?
The 52-week low of Alzamend Neuro Inc is 0.84.
What is the market capitalization of Alzamend Neuro Inc?
The market capitalization of Alzamend Neuro Inc is 113.35K.
Is Alzamend Neuro Inc (ALZN) currently rated as Buy, Hold, or Sell?
According to analysts, Alzamend Neuro Inc (ALZN) has an overall rating of Buy, with a price target of 25.00.
What is the Earnings Per Share (EPS TTM) of Alzamend Neuro Inc (ALZN)?
The Earnings Per Share (EPS TTM) of Alzamend Neuro Inc (ALZN) is -2.63.